- Last edited on January 25, 2022
Differences
This shows you the differences between two versions of the page.
|
meds:agitation [on May 16, 2019] |
meds:agitation [on December 17, 2019] |
||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | {{tag>rx}} | + | f{{tag>rx}} |
| ====== Pharmacological Management of Acute Agitation ====== | ====== Pharmacological Management of Acute Agitation ====== | ||
| {{INLINETOC}} | {{INLINETOC}} | ||
| Line 32: | Line 32: | ||
| ==== Zuclopenthixol ==== | ==== Zuclopenthixol ==== | ||
| - | <callout type="success">{{fa>arrow-circle-right?color=green}} See also main article: **[[meds:antipsychotics:first-gen-typical-antipsychotics:4-zuclopenthixol]]**</callout> | + | <callout type="success">{{fa>arrow-circle-right?color=green}} See also main article: **[[meds:antipsychotics:first-gen-typical:4-zuclopenthixol]]**</callout> |
| ===== Choosing a Benzodiazepine ===== | ===== Choosing a Benzodiazepine ===== | ||
| Line 85: | Line 85: | ||
| == For Providers == | == For Providers == | ||
| * [[http://escholarship.org/uc/item/5fz8c8gs|Wilson, Michael P.; Pepper, David; Currier, Glenn W.; Holloman, Garland H.; & Feifel, David. (2012). The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. Western Journal of Emergency Medicine, 13(1).]] | * [[http://escholarship.org/uc/item/5fz8c8gs|Wilson, Michael P.; Pepper, David; Currier, Glenn W.; Holloman, Garland H.; & Feifel, David. (2012). The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. Western Journal of Emergency Medicine, 13(1).]] | ||
| + | * [[https://www.psychiatryadvisor.com/home/opinion/haloperidol-in-the-emergency-department-setting/|PsychiatryAdvisor: Haloperidol in the Emergency Department Setting]] | ||